-
Published 6/30/2026
Hamer DH, Loreau JM, Huits R, Díaz-Menéndez M, Grobusch MP, Barkati S, Yansouni CP, Gobbi F, Bottieau E, Chen LH, Duvignaud A, Malvy D, Castelli F, Odolini S, De Pijper CA, Asgeirsson H, Moro L, Yamamoto K, Sánchez-Montalvá A, Zeana C, Kelly P, Piyaphanee W, Bourque DL, McCarthy A, Simon F, Gautret P, Mardon JB, Texier G, Javelle E. Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study. J Travel Med. 2026 Jun 30; 33(5). PMID: 42149962.
-
Published 3/10/2026
Carrion MN, Kienle RM, Bourque D, Drainoni ML, Hochberg NS, Dauphinais M, Mello T, Stigler Granados PE, Hamer DH. Barriers to Chagas Disease Screening among Primary Care Providers in the United States. Am J Trop Med Hyg. 2026 May 06; 114(5):857-864. PMID: 41806373.
-
Published 1/30/2026
Tabackman A, Acuña-Villaorduña C, Canning M, Karoly M, Dauphinais MR, Michaud R, Bouton TC, Bourque DL, Reifler KA, Sabharwal V, Traber K, Gupte AN, Jacobson KR, Sinha P. Low TB1 and TB2 antigen-nil is associated with increased QuantiFERON Gold Plus reversions. Int J Tuberc Lung Dis. 2026 Jan 30; 30(2):88-89. PMID: 41618115.
-
Published 1/2/2026
Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Shorter regimens for TB preventive treatment: implementation challenges and priorities. Int J Tuberc Lung Dis. 2026 Jan 02; 30(1):43-44. PMID: 41482619.
-
Published 8/29/2025
Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Rifampin versus isoniazid completion rates for TB infection. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):425-427. PMID: 40883884.